We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Clarifies Considerations for Switching Devices From Rx to OTC Status
FDA Clarifies Considerations for Switching Devices From Rx to OTC Status
The FDA issued an update on which types of devices may be offered as over the counter (OTC) devices and what devicemakers should consider when making the switch from prescription to OTC status.
To View This Article:
Login
Subscribe To International Devices & Diagnostics Monitor